메뉴 건너뛰기




Volumn 13, Issue 11, 2007, Pages 1099-1104

Vasoactive intestinal peptide receptors: A molecular target in breast and lung cancer

Author keywords

Breast cancer; Lung cancer; PACAP; Receptors; VIP

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; ELLIPTICINE DERIVATIVE; GEMCITABINE; GROWTH HORMONE RELEASING FACTOR; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR 1; IRINOTECAN; MESSENGER RNA; NAVELBINE; NEUROTENSIN[6-11] VASOACTIVE INTESTINAL POLYPEPTIDE[7-28]; PEPTIDE HORMONE RECEPTOR BLOCKING AGENT; RETINOIC ACID; RO 25 1553; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE ANTAGONIST; VASOACTIVE INTESTINAL POLYPEPTIDE LEUCYLALANYLLEUCYLALANINE ELLIPTICINE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 1; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 2;

EID: 34248340573     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161207780619000     Document Type: Review
Times cited : (39)

References (69)
  • 1
    • 2542440077 scopus 로고    scopus 로고
    • Molecular biology of breast cancer
    • DeVita Jr VT, Hellman S, Rosenberg SA Eds, Philadelphia, Lippincott-Raven Press
    • Dickson RB, Lippman ME. Molecular biology of breast cancer. In: DeVita Jr VT, Hellman S, Rosenberg SA Eds, Cancer: Principles & practice of oncology. Philadelphia, Lippincott-Raven Press 2001; 1633-51.
    • (2001) Cancer: Principles & practice of oncology , pp. 1633-1651
    • Dickson, R.B.1    Lippman, M.E.2
  • 2
    • 1842614245 scopus 로고    scopus 로고
    • Safety of treatment of metastatic breast cancer with trastuzumab beyond disease progression
    • Tripathy D, Slamon DJ, Cobleigh M, Arnold A, Saleh M, Mortimer JE, et al. Safety of treatment of metastatic breast cancer with trastuzumab beyond disease progression. J Clin Oncol 2004; 22: 1063-70.
    • (2004) J Clin Oncol , vol.22 , pp. 1063-1070
    • Tripathy, D.1    Slamon, D.J.2    Cobleigh, M.3    Arnold, A.4    Saleh, M.5    Mortimer, J.E.6
  • 3
    • 0037125422 scopus 로고    scopus 로고
    • Adjuvant therapy for postmenopausal lymph node-negative breast cancer: It ain't necessarily so
    • Wolff AC, Abeloff MD. Adjuvant therapy for postmenopausal lymph node-negative breast cancer: It ain't necessarily so. J Natl Cancer Inst 2002; 94: 1041-3.
    • (2002) J Natl Cancer Inst , vol.94 , pp. 1041-1043
    • Wolff, A.C.1    Abeloff, M.D.2
  • 5
    • 0002478350 scopus 로고    scopus 로고
    • Malignant tumors of the breast
    • DeVita Jr VT, Hellman S, Rosenberg SA Eds, Philadelphia, Lippincott-Raven Press
    • Winer EP, Morrow M, Osborne CK, Harris JR. Malignant tumors of the breast. In: DeVita Jr VT, Hellman S, Rosenberg SA Eds, Cancer: Principles & practice of oncology. Philadelphia, Lippincott-Raven Press 2001; 1651-717.
    • (2001) Cancer: Principles & practice of oncology , pp. 1651-1717
    • Winer, E.P.1    Morrow, M.2    Osborne, C.K.3    Harris, J.R.4
  • 6
    • 27944492407 scopus 로고    scopus 로고
    • Tamoxifen for the prevention of breast cancer: Current status of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
    • Fisher B, Costantino JP, Wickerham DL, Cecchini WM, Cronin WM, Robidoux, A et al. Tamoxifen for the prevention of breast cancer: Current status of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J. Natl Cancer Inst 2005; 97: 1652-62.
    • (2005) J. Natl Cancer Inst , vol.97 , pp. 1652-1662
    • Fisher, B.1    Costantino, J.P.2    Wickerham, D.L.3    Cecchini, W.M.4    Cronin, W.M.5    Robidoux, A.6
  • 7
    • 0023694907 scopus 로고    scopus 로고
    • Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells
    • Gespach C, Bawab W, Decremoux P, Calvo F. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells. Cancer Res 1998; 48: 5079-83.
    • (1998) Cancer Res , vol.48 , pp. 5079-5083
    • Gespach, C.1    Bawab, W.2    Decremoux, P.3    Calvo, F.4
  • 8
    • 0029074449 scopus 로고
    • Differential expression of VIP/PACAP receptor genes in breast, intestinal and pancreatic cancer cell lines
    • Waschek JL, Richards ML, Bravo DT. Differential expression of VIP/PACAP receptor genes in breast, intestinal and pancreatic cancer cell lines. Cancer Lett 1995; 92:143-9.
    • (1995) Cancer Lett , vol.92 , pp. 143-149
    • Waschek, J.L.1    Richards, M.L.2    Bravo, D.T.3
  • 9
    • 0029684332 scopus 로고    scopus 로고
    • Breast cancer growth is inhibited by VIPhybrid, a synthetic VIP receptor antagonist
    • Zia H, Hida T, Jakowlew S, Birrer M, Gozes Y, Reubi JC, et al. Breast cancer growth is inhibited by VIPhybrid, a synthetic VIP receptor antagonist. Cancer Res 1996; 56: 3486-9.
    • (1996) Cancer Res , vol.56 , pp. 3486-3489
    • Zia, H.1    Hida, T.2    Jakowlew, S.3    Birrer, M.4    Gozes, Y.5    Reubi, J.C.6
  • 10
    • 0029808748 scopus 로고    scopus 로고
    • Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways
    • Whitmarsh AJ, Davis RJ. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J. Mol Med 1996; 74: 589-607.
    • (1996) J. Mol Med , vol.74 , pp. 589-607
    • Whitmarsh, A.J.1    Davis, R.J.2
  • 11
    • 0034746386 scopus 로고    scopus 로고
    • Prostaglandin E2 and VIP increases vascular endothelial cell growth factor mRNAs in lung cancer cells
    • Casibang M, Purdom S, Zia F, Jakowlew S, Neckers L, Ben-Av P, et al. Prostaglandin E2 and VIP increases vascular endothelial cell growth factor mRNAs in lung cancer cells. Lung Cancer 2001; 31:203-12.
    • (2001) Lung Cancer , vol.31 , pp. 203-212
    • Casibang, M.1    Purdom, S.2    Zia, F.3    Jakowlew, S.4    Neckers, L.5    Ben-Av, P.6
  • 14
    • 0035886469 scopus 로고    scopus 로고
    • A lipophilic vasoactive intestinal peptide analog enhances the antiproliferative effect of chemotherapeutic agents on cancer cell lines
    • Gelber E, Granoth R, Fridkin M, Dreznik Z, Brenneman DE, Moody TW, et al. A lipophilic vasoactive intestinal peptide analog enhances the antiproliferative effect of chemotherapeutic agents on cancer cell lines. Cancer 2001; 92: 2172-80.
    • (2001) Cancer , vol.92 , pp. 2172-2180
    • Gelber, E.1    Granoth, R.2    Fridkin, M.3    Dreznik, Z.4    Brenneman, D.E.5    Moody, T.W.6
  • 15
    • 0037135257 scopus 로고    scopus 로고
    • VIP-ellipticine derivatives inhibit the growth of breast cancer cells
    • Moody TW, Czerwinski G, Tarasova NI, Michejda CJ. VIP-ellipticine derivatives inhibit the growth of breast cancer cells. Life Sci 2002; 19: 1005-14.
    • (2002) Life Sci , vol.19 , pp. 1005-1014
    • Moody, T.W.1    Czerwinski, G.2    Tarasova, N.I.3    Michejda, C.J.4
  • 16
    • 0021391337 scopus 로고
    • Studies toward the biosynthesis of vasoactive intestinal peptide
    • Gozes I, Bodner M, Shwratz H, Shani T, Fridkin M. Studies toward the biosynthesis of vasoactive intestinal peptide. Peptides 1984; 5: 161-6.
    • (1984) Peptides , vol.5 , pp. 161-166
    • Gozes, I.1    Bodner, M.2    Shwratz, H.3    Shani, T.4    Fridkin, M.5
  • 18
    • 0030155599 scopus 로고    scopus 로고
    • Regulation of VIP gene expression. Molecular and Cellular
    • Davidson A, Moody TW, Gozes I. Regulation of VIP gene expression. Molecular and Cellular Neurosci 1996; 7: 99-110.
    • (1996) Neurosci , vol.7 , pp. 99-110
    • Davidson, A.1    Moody, T.W.2    Gozes, I.3
  • 19
    • 0014954352 scopus 로고
    • Polypeptide with broad biological activity: Isolation from small intestine
    • Said SI, Mutt V. Polypeptide with broad biological activity: Isolation from small intestine. Science 1970; 69: 1217-8.
    • (1970) Science , vol.69 , pp. 1217-1218
    • Said, S.I.1    Mutt, V.2
  • 20
    • 0025075727 scopus 로고
    • Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38)
    • Miyata A, Jiang L, Dahl RD, Kitada, C, Kubo K, Fujino M, et al. Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38). Biochem Biophys Res Commun 1990; 170: 643-8.
    • (1990) Biochem Biophys Res Commun , vol.170 , pp. 643-648
    • Miyata, A.1    Jiang, L.2    Dahl, R.D.3    Kitada, C.4    Kubo, K.5    Fujino, M.6
  • 21
    • 0024415355 scopus 로고
    • Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells
    • Miyata A, Arimura A, Dahl RR, Minamino N, Uehara A, Jiang L, et al. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun 1989; 164: 567-74.
    • (1989) Biochem Biophys Res Commun , vol.164 , pp. 567-574
    • Miyata, A.1    Arimura, A.2    Dahl, R.R.3    Minamino, N.4    Uehara, A.5    Jiang, L.6
  • 22
    • 0034604577 scopus 로고    scopus 로고
    • Identification of key residues for interaction of vasoactive intestinal peptide with human VPAC1 and VPAC2 receptors and development of a highly selective VPAC1 receptor agonist. Alanine scanning and molecular modeling of the peptide
    • Nicole P, Lins L, Rouyer-Fessard C, Drouot C, Fulcrand P, Thomas A, et al. Identification of key residues for interaction of vasoactive intestinal peptide with human VPAC1 and VPAC2 receptors and development of a highly selective VPAC1 receptor agonist. Alanine scanning and molecular modeling of the peptide. J Biol Chem 2000; 275: 24003-12.
    • (2000) J Biol Chem , vol.275 , pp. 24003-24012
    • Nicole, P.1    Lins, L.2    Rouyer-Fessard, C.3    Drouot, C.4    Fulcrand, P.5    Thomas, A.6
  • 23
    • 0036127636 scopus 로고    scopus 로고
    • Elucidation of vasoactive intestinal peptide pharmacophore for VPAC(1) receptors in human, rat and guinea pig
    • Igarashi H, Ito T, Hou W, Mantey SA, Pradhan TK, Ulrich CD, et al. Elucidation of vasoactive intestinal peptide pharmacophore for VPAC(1) receptors in human, rat and guinea pig. J Pharmacol Exp Ther 2002; 301: 37-50.
    • (2002) J Pharmacol Exp Ther , vol.301 , pp. 37-50
    • Igarashi, H.1    Ito, T.2    Hou, W.3    Mantey, S.A.4    Pradhan, T.K.5    Ulrich, C.D.6
  • 24
    • 0017106186 scopus 로고
    • Interaction of peptides related to secretin with hormone receptors on pancreatic acinar cells
    • Gardner JD, Conlon TP, Fink ML, Bodanszky M. Interaction of peptides related to secretin with hormone receptors on pancreatic acinar cells. Gastroenterology 1976; 71: 965-70.
    • (1976) Gastroenterology , vol.71 , pp. 965-970
    • Gardner, J.D.1    Conlon, T.P.2    Fink, M.L.3    Bodanszky, M.4
  • 26
    • 0028261933 scopus 로고
    • A chimeric VIP-PACAP analogue but not VIP pseudopeptides. function as VIP receptor antagonists
    • Fishbein VA, Coy DH, Hocart SJ, Jiang NY, Mrozinski Jr JE, Mantey SA, et al. A chimeric VIP-PACAP analogue but not VIP pseudopeptides. function as VIP receptor antagonists. Peptides 1994; 15: 95-100.
    • (1994) Peptides , vol.15 , pp. 95-100
    • Fishbein, V.A.1    Coy, D.H.2    Hocart, S.J.3    Jiang, N.Y.4    Mrozinski Jr, J.E.5    Mantey, S.A.6
  • 29
    • 0021813720 scopus 로고
    • Interaction of growth hormone-releasing factor (GRF) and 14 GRF analogs with vasoactive intestinal peptide (VIP) receptors of rat pancreas. Discovery of (N-Ac-Tyrl, D-Phe2)-GRP(1-29)NH2 as a VIP antagonist
    • Waelbroeck M, Robberecht P, Coy DH, Camus JC, DeNeef P, Christophe J. Interaction of growth hormone-releasing factor (GRF) and 14 GRF analogs with vasoactive intestinal peptide (VIP) receptors of rat pancreas. Discovery of (N-Ac-Tyrl, D-Phe2)-GRP(1-29)NH2 as a VIP antagonist. Endocrinology 1985; 116: 2643-9.
    • (1985) Endocrinology , vol.116 , pp. 2643-2649
    • Waelbroeck, M.1    Robberecht, P.2    Coy, D.H.3    Camus, J.C.4    DeNeef, P.5    Christophe, J.6
  • 30
    • 0025832239 scopus 로고
    • A hybrid antagonist to vasoactive intestinal peptide: Effects on cellular function in the central nervous system
    • Gozes I, McCune SK, Jacobson L, Warren D, Moody TW, Fridkin M, et al. A hybrid antagonist to vasoactive intestinal peptide: Effects on cellular function in the central nervous system. J Pharm Exp Ther 1991; 257: 959-66.
    • (1991) J Pharm Exp Ther , vol.257 , pp. 959-966
    • Gozes, I.1    McCune, S.K.2    Jacobson, L.3    Warren, D.4    Moody, T.W.5    Fridkin, M.6
  • 31
    • 0030613760 scopus 로고    scopus 로고
    • (Stearyl, Norleucine17)VIPhyb is a potent non-small lung cancer VIP receptor antagonist
    • Moody TW, Leyton J, Coelho T, Knight M, Takahashi K, Koh M, et al. (Stearyl, Norleucine17)VIPhyb is a potent non-small lung cancer VIP receptor antagonist. Life Sci 1997; 17: 1657-66.
    • (1997) Life Sci , vol.17 , pp. 1657-1666
    • Moody, T.W.1    Leyton, J.2    Coelho, T.3    Knight, M.4    Takahashi, K.5    Koh, M.6
  • 32
    • 0026511295 scopus 로고
    • Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide
    • Ishihara T, Shigemoto R, Mori K, Takahashi K, Nagata S. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide. Neuron 1992; 8: 811-9.
    • (1992) Neuron , vol.8 , pp. 811-819
    • Ishihara, T.1    Shigemoto, R.2    Mori, K.3    Takahashi, K.4    Nagata, S.5
  • 33
    • 0027332401 scopus 로고
    • The VIP2 receptor: Molecular characterization of a cDNA encoding a novel receptor for vasoactive intestinal peptide
    • Lutz EM, Sheward WJ, West KM, Morrow JA, Harmar AJ. The VIP2 receptor: Molecular characterization of a cDNA encoding a novel receptor for vasoactive intestinal peptide. FEBS Lett 1993; 334: 3-8.
    • (1993) FEBS Lett , vol.334 , pp. 3-8
    • Lutz, E.M.1    Sheward, W.J.2    West, K.M.3    Morrow, J.A.4    Harmar, A.J.5
  • 34
    • 0027281138 scopus 로고
    • Molecular cloning and functional expression of the pituitary adenylate cyclase-activating polypeptide type I receptor
    • Pisegna J, Wank SA Molecular cloning and functional expression of the pituitary adenylate cyclase-activating polypeptide type I receptor. Proc Natl Acad Sci USA 1993; 90: 6345-9.
    • (1993) Proc Natl Acad Sci USA , vol.90 , pp. 6345-6349
    • Pisegna, J.1    Wank, S.A.2
  • 35
    • 0027240588 scopus 로고
    • Differential signal transduction by five splice variants of the PACAP receptor
    • Spengler D, Waeber C, Pantaloni C, Holsboe F, Bockaert J, Seeberg P, et al. Differential signal transduction by five splice variants of the PACAP receptor. Nature 1993; 365: 170-5.
    • (1993) Nature , vol.365 , pp. 170-175
    • Spengler, D.1    Waeber, C.2    Pantaloni, C.3    Holsboe, F.4    Bockaert, J.5    Seeberg, P.6
  • 37
    • 0028949426 scopus 로고
    • Design and development of a vasoactive intestinal peptide analog as a novel therapeutic for bronchial asthma
    • Bolin DR, Michelewsky J, Wasserman MA, O'Donnell M. Design and development of a vasoactive intestinal peptide analog as a novel therapeutic for bronchial asthma. Biopolymers 1995; 37: 57-66.
    • (1995) Biopolymers , vol.37 , pp. 57-66
    • Bolin, D.R.1    Michelewsky, J.2    Wasserman, M.A.3    O'Donnell, M.4
  • 38
    • 0028825878 scopus 로고
    • Neuropeptide reccceptors in health and disease: The molecular basis for in vivo imaging
    • Reubi JC. Neuropeptide reccceptors in health and disease: The molecular basis for in vivo imaging. J Nucl Med 1995; 36: 25-35.
    • (1995) J Nucl Med , vol.36 , pp. 25-35
    • Reubi, J.C.1
  • 39
    • 18144453553 scopus 로고    scopus 로고
    • Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin
    • Reubi JC, Laderach U, Waser B, Gebbers JO, Robberecht P, Laissue JA. Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin. Cancer Res 2000; 60: 3105-12.
    • (2000) Cancer Res , vol.60 , pp. 3105-3112
    • Reubi, J.C.1    Laderach, U.2    Waser, B.3    Gebbers, J.O.4    Robberecht, P.5    Laissue, J.A.6
  • 40
    • 0037728734 scopus 로고    scopus 로고
    • VIP and PACAP receptors coupled to adenylyl cyclase in human lung cancer: A study in biopsy specimens
    • Busto R, Prieto JC, Bodega G, Zapatero J, Fogue L, Carrero O. VIP and PACAP receptors coupled to adenylyl cyclase in human lung cancer: A study in biopsy specimens. Peptides 2003; 24: 429-36.
    • (2003) Peptides , vol.24 , pp. 429-436
    • Busto, R.1    Prieto, J.C.2    Bodega, G.3    Zapatero, J.4    Fogue, L.5    Carrero, O.6
  • 42
    • 0025649568 scopus 로고
    • Vasoactive intestinal peptide binds with high affinity to non-small cell lung cancer cells and elevates cAMP levels
    • Lee M, Jensen RT, Huang SC, Bepler G, Korman L, Moody TW. Vasoactive intestinal peptide binds with high affinity to non-small cell lung cancer cells and elevates cAMP levels. Peptides 1990; 11: 1205-10.
    • (1990) Peptides , vol.11 , pp. 1205-1210
    • Lee, M.1    Jensen, R.T.2    Huang, S.C.3    Bepler, G.4    Korman, L.5    Moody, T.W.6
  • 44
    • 0025675464 scopus 로고
    • Characterization of VIP- and helodermin-preferring receptors on human small cell lung carcinoma cell lines
    • Luis J, Said SI. Characterization of VIP- and helodermin-preferring receptors on human small cell lung carcinoma cell lines. Peptides 1990; 11: 1239-44.
    • (1990) Peptides , vol.11 , pp. 1239-1244
    • Luis, J.1    Said, S.I.2
  • 46
    • 0028047017 scopus 로고
    • Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumors
    • Virgolini I, Raderer M, Kurtaran A, Angelberger P, Banyai S, Yang Q, et al. Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumors. New Eng J Med 1994; 331: 1116-21.
    • (1994) New Eng J Med , vol.331 , pp. 1116-1121
    • Virgolini, I.1    Raderer, M.2    Kurtaran, A.3    Angelberger, P.4    Banyai, S.5    Yang, Q.6
  • 47
    • 0034021858 scopus 로고    scopus 로고
    • Value of peptide receptor scintigraphy using (123)I-vasoactive intestinal peptide and (111)In-DTPA-D-Pheloctreotide in 194 carcionoid patients: Vienna University Experience, 1993-1998
    • Raderer M, Kurtaran A, Leimer M, Angelberger P, Niederle B, Vierhapper H, et al. Value of peptide receptor scintigraphy using (123)I-vasoactive intestinal peptide and (111)In-DTPA-D-Pheloctreotide in 194 carcionoid patients: Vienna University Experience, 1993-1998. J Clin Oncol 2000; 18: 1331-6.
    • (2000) J Clin Oncol , vol.18 , pp. 1331-1336
    • Raderer, M.1    Kurtaran, A.2    Leimer, M.3    Angelberger, P.4    Niederle, B.5    Vierhapper, H.6
  • 48
    • 0032588617 scopus 로고    scopus 로고
    • 99mTc-labeled vasoactive intestinal peptide receptor agonist: Functional studies
    • Pallela VR, Thakur ML, Chakder S, Rattan S. 99mTc-labeled vasoactive intestinal peptide receptor agonist: Functional studies. J Nucl Med 1999; 93: 352-60.
    • (1999) J Nucl Med , vol.93 , pp. 352-360
    • Pallela, V.R.1    Thakur, M.L.2    Chakder, S.3    Rattan, S.4
  • 49
    • 0036842080 scopus 로고    scopus 로고
    • Radiolabeled peptides in the diagnosis and therapy of oncological diseases
    • Weiner R, Thakur M. Radiolabeled peptides in the diagnosis and therapy of oncological diseases. Appl Radiat Isot 2003; 51: 749-63.
    • (2003) Appl Radiat Isot , vol.51 , pp. 749-763
    • Weiner, R.1    Thakur, M.2
  • 51
    • 0022551233 scopus 로고
    • Secretin/VIP stimulated secretion of bombesin-like peptides from human small cell lung cancer
    • Korman LY, Carney DN, Citron ML, Moody TW. Secretin/VIP stimulated secretion of bombesin-like peptides from human small cell lung cancer. Cancer Res. 1986; 46: 1214-8.
    • (1986) Cancer Res , vol.46 , pp. 1214-1218
    • Korman, L.Y.1    Carney, D.N.2    Citron, M.L.3    Moody, T.W.4
  • 52
    • 0030035113 scopus 로고    scopus 로고
    • Cloning and characterization of the signal transduction of four splice variants of the human pituitary adenylate cyclase activating polypeptide receptor. Evidence for dual coupling to adenylate cyclasae and phospholipase C
    • Pisegna JR, Wank SA. Cloning and characterization of the signal transduction of four splice variants of the human pituitary adenylate cyclase activating polypeptide receptor. Evidence for dual coupling to adenylate cyclasae and phospholipase C. J Biol Chem 1996; 271: 17267-74.
    • (1996) J Biol Chem , vol.271 , pp. 17267-17274
    • Pisegna, J.R.1    Wank, S.A.2
  • 53
    • 0037111308 scopus 로고    scopus 로고
    • PACAP-27 tyrosine phosphorylates mitogen activated protein kinase and increases VEGF mRNAs in human lung cancer cells
    • Moody TW, Leyton J, Casibang M, Pisegna J, Jensen RT. PACAP-27 tyrosine phosphorylates mitogen activated protein kinase and increases VEGF mRNAs in human lung cancer cells. Reg Peptides 2002; 109: 135-40.
    • (2002) Reg Peptides , vol.109 , pp. 135-140
    • Moody, T.W.1    Leyton, J.2    Casibang, M.3    Pisegna, J.4    Jensen, R.T.5
  • 55
    • 0026516701 scopus 로고
    • Vasoactive intestinal peptide as an autocrine growth factor in neuroblastoma
    • O'Dorisio MS, Fleshman DJ, Qualman SJ, O'Dorisio TM. Vasoactive intestinal peptide as an autocrine growth factor in neuroblastoma. Reg Peptides 1992; 37: 213-26.
    • (1992) Reg Peptides , vol.37 , pp. 213-226
    • O'Dorisio, M.S.1    Fleshman, D.J.2    Qualman, S.J.3    O'Dorisio, T.M.4
  • 56
    • 0032942884 scopus 로고    scopus 로고
    • Vasoactive intestinal peptide (VIP) and VIP receptors: Gene expression and growth modulation in medulloblastoma, and other central primitive neuroectodermal tumors of childhood
    • Fruhwald MC, O'Dorisio MS, Fleitz J, Pietsch T, Reubi, JC. Vasoactive intestinal peptide (VIP) and VIP receptors: Gene expression and growth modulation in medulloblastoma, and other central primitive neuroectodermal tumors of childhood. Int J Cancer 1999, 81: 165-73.
    • (1999) Int J Cancer , vol.81 , pp. 165-173
    • Fruhwald, M.C.1    O'Dorisio, M.S.2    Fleitz, J.3    Pietsch, T.4    Reubi, J.C.5
  • 57
    • 0027298058 scopus 로고
    • Small-cell lung carcinoma: Inhibition of proliferation by vasoactive intestinal peptide and helodermin and enhancement of inhibition by anti-bombesin antibody
    • Maruno K, Said SI. Small-cell lung carcinoma: Inhibition of proliferation by vasoactive intestinal peptide and helodermin and enhancement of inhibition by anti-bombesin antibody. Life Sci 1993; 52: 267-71.
    • (1993) Life Sci , vol.52 , pp. 267-271
    • Maruno, K.1    Said, S.I.2
  • 58
    • 0031846762 scopus 로고    scopus 로고
    • Vasoactive intestinal peptide shortens both G1 and S phases of neural cell cycle in whole postimplantation cultured mouse embryos
    • Gressons P, Paindaveine B, Hill JM, Evrard P, Brenneman DE. Vasoactive intestinal peptide shortens both G1 and S phases of neural cell cycle in whole postimplantation cultured mouse embryos. Eur J Neurosci 1998; 10: 1734-42.
    • (1998) Eur J Neurosci , vol.10 , pp. 1734-1742
    • Gressons, P.1    Paindaveine, B.2    Hill, J.M.3    Evrard, P.4    Brenneman, D.E.5
  • 59
    • 0033813160 scopus 로고    scopus 로고
    • 9-Cis retinoic acid suppresses mammary tumorigenesis in C3(1)-simian virus 40 T antigen transgenic mice
    • Wu K, Kim HT, Rodriguez, JL, Munoz-Medellin D, Moshsin SK, Hilsenbeck SG, et al. 9-Cis retinoic acid suppresses mammary tumorigenesis in C3(1)-simian virus 40 T antigen transgenic mice. Clin Cancer Res 2000; 6: 3696-704.
    • (2000) Clin Cancer Res , vol.6 , pp. 3696-3704
    • Wu, K.1    Kim, H.T.2    Rodriguez, J.L.3    Munoz-Medellin, D.4    Moshsin, S.K.5    Hilsenbeck, S.G.6
  • 60
    • 0347360143 scopus 로고    scopus 로고
    • VIP receptor antagonists inhibit mammary carcinogenesis in C3(1)SV40 transgenic mice
    • Moody TW, Dudek J, Zakowicz H, Walters J, Jensen RT, Petricoin EM, et al. VIP receptor antagonists inhibit mammary carcinogenesis in C3(1)SV40 transgenic mice. Life Sci 2004; 74: 1345-57.
    • (2004) Life Sci , vol.74 , pp. 1345-1357
    • Moody, T.W.1    Dudek, J.2    Zakowicz, H.3    Walters, J.4    Jensen, R.T.5    Petricoin, E.M.6
  • 61
    • 0032212489 scopus 로고    scopus 로고
    • Retinoic acid down regulates the expression of the vasoactive intestinal receptor
    • Madsen B, Georg B, Vissing H, Fahrenkrug J. Retinoic acid down regulates the expression of the vasoactive intestinal receptor. Cancer Res 1998; 58: 4845-50.
    • (1998) Cancer Res , vol.58 , pp. 4845-4850
    • Madsen, B.1    Georg, B.2    Vissing, H.3    Fahrenkrug, J.4
  • 62
    • 0034861164 scopus 로고    scopus 로고
    • Retinoic acid increased VPAC1 receptors and transforming growth factor β2 in non-small cell lung cancer cells
    • Jakowlew S, Zakowicz,H, Moody TW. Retinoic acid increased VPAC1 receptors and transforming growth factor β2 in non-small cell lung cancer cells. Peptides 1999; 21: 1831-7.
    • (1999) Peptides , vol.21 , pp. 1831-1837
    • Jakowlew, S.1    Zakowicz, H.2    Moody, T.W.3
  • 63
    • 0037063712 scopus 로고    scopus 로고
    • A vasoactive intestinal peptide receptor analog alters the expression of homeobox. genes
    • Steingart RA, Heldenberg E, Pinhasov A, Brenneman DE, Fridkin M, Gozes, A vasoactive intestinal peptide receptor analog alters the expression of homeobox. genes. Life Sci 2002; 71: 2543-52.
    • (2002) Life Sci , vol.71 , pp. 2543-2552
    • Steingart, R.A.1    Heldenberg, E.2    Pinhasov, A.3    Brenneman, D.E.4    Fridkin, M.5    Gozes6
  • 65
    • 0001552354 scopus 로고    scopus 로고
    • DeVita VT, Hellman S, Rosenberg SA Eds, Molecular biology of lung cancer
    • Philadelphia, Lippincott-Raven Press
    • Sekido Y, Fong WM, Minna JD. In: DeVita VT, Hellman S, Rosenberg SA Eds, Molecular biology of lung cancer. Cancer: Principles and practice of oncology, Philadelphia, Lippincott-Raven Press 2001; 917-25.
    • (2001) Cancer: Principles and practice of oncology , pp. 917-925
    • Sekido, Y.1    Fong, W.M.2    Minna, J.D.3
  • 66
    • 0035467993 scopus 로고    scopus 로고
    • Global cancer statistics in the year 2000
    • Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001; 2: 533-43.
    • (2001) Lancet Oncol , vol.2 , pp. 533-543
    • Parkin, D.M.1
  • 67
    • 11844251275 scopus 로고    scopus 로고
    • Development of molecular targeted anticancer agents: Successes, failures and future directions
    • Chen E. X, Siu L. L. Development of molecular targeted anticancer agents: Successes, failures and future directions. Curr Pharm Des 2005; 11(2): 265-72.
    • (2005) Curr Pharm Des , vol.11 , Issue.2 , pp. 265-272
    • Chen, E.X.1    Siu, L.L.2
  • 69
    • 24944527548 scopus 로고    scopus 로고
    • Immunotherapy and cancer vaccines in the management of breast cancer
    • Sauer G, Kurzeder C, Heilmann V, Kreienberg R, Deissler H. Immunotherapy and cancer vaccines in the management of breast cancer. Curr Pharm Des 2005; 11(27): 3475-83.
    • (2005) Curr Pharm Des , vol.11 , Issue.27 , pp. 3475-3483
    • Sauer, G.1    Kurzeder, C.2    Heilmann, V.3    Kreienberg, R.4    Deissler, H.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.